Respiratory regulation in narcolepsy

Sleep and Breathing

Volumn 16, Issue 1, 2012, Pages 241-245

  Han, Fang ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Narcolepsy; Orexins; Respiratory regulation

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; HLA DQB1 ANTIGEN; OREXIN; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; OREXIN A;

ARTICLE; CATAPLEXY; EVIDENCE BASED MEDICINE; HUMAN; HYPERCAPNIA; MICRODIALYSIS; NARCOLEPSY; NERVE CELL; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIORITY JOURNAL; RESPIRATION CONTROL; SLEEP APNEA SYNDROME;

ANIMALS; CATAPLEXY; CHEMORECEPTOR CELLS; GENETIC MARKERS; HLA-DQ BETA-CHAINS; HUMANS; HYPERCAPNIA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; NARCOLEPSY; NEURONS; NEUROPEPTIDES; OXYGEN; SLEEP APNEA, OBSTRUCTIVE;

EID: 84859161481     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-011-0489-x     Document Type: Article

References (37)

1. Weil JV (2003) Variation in human ventilatory control-genetic influence on the hypoxic ventilatory response. Respir Physiol Neurobiol 135:239-246
2. Han F, Strohl KP (2000) Inheritance of ventilatory behavior in rodent models. Respir Physiol 121:247-256
3. Mieda M, Sakurai T (2009) Integrative physiology of orexins and orexin receptors. CNS Neurol Disord Drug Targets 8:281-295
4. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, Mignot E (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98:365-376
5. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98:437-451
6. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355:39-40
7. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucherlapati R, Nishino S, Mignot E (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6:991-997
8. Lin L, Jin L, Kimura A, Carrington M, Mignot E (1997) DQ microsatellite association studies in three ethnic groups. Tissue Antigens 50:507-520
9. Nakamura A, Zhang W, Yanagisawa M, Fukuda Y, Kuwaki T (2007) Vigilance state-dependent attenuation of hypercapnic chemoreflex and exaggerated sleep apnea in orexin knockout mice. J Appl Physiol 102:241-248
10. Deng BS, Nakamura A, Zhang W, Yanagisawa M, Fukuda Y, Kuwaki T (2007) Contribution of orexin in hypercapnic chemoreflex: evidence from genetic and pharmacological disruption and supplementation studies in mice. J Appl Physiol 103:1772-1779
11. Chokroverty S (1986) Sleep apnea in narcolepsy. Sleep 9:250-253
12. Plazzi G, Serra L, Ferri R (2008) Nocturnal aspects of narcolepsy with cataplexy. Sleep Med Rev 12:109-128
13. Dias MB, Li A, Nattie E (2010) The orexin receptor 1 (OX1R) in the rostral medullary raphe contributes to the hypercapnic chemoreflex in wakefulness, during the active period of the diurnal cycle. Respir Physiol Neurobiol 170:96-102
14. Dias MB, Li A, Nattie EE (2009) Antagonism of orexin receptor-1 in the retrotrapezoid nucleus inhibits the ventilatory response to hypercapnia predominantly in wakefulness. J Physiol 587:2059-2067
15. Li A, Nattie EE (2010) Antagonism of rat orexin receptors by almorexant attenuates central chemoreception in wakefulness in the active period of the diurnal cycle. J Physiol 588:2935-2944
16. Kuwaki T (2008) Orexinergic modulation of breathing across vigilance states. Respir Physiol Neurobiol 164:204-212
17. Kuwaki T, Li A, Nattie E (2010) State-dependent central chemoreception: a role of orexin. Respir Physiol Neurobiol 173:223-229
18. Nattie E, Li A (2010) Central chemoreception in wakefulness and sleep: evidence for a distributed network and a role for orexin. J Appl Physiol 108:1417-1424
19. Han F, Mignot E, Wei YC, Dong SX, Li J, Lin L, An P, Wang LH, Wang JS, He MZ, Gao HY, Li M, Gao ZC, Strohl KP (2010) Ventilatory chemoresponsiveness, narcolepsy-cataplexy, and HLA-DQB1*0602 status. Eur Respir J 36:577-583
20. Stornetta RL (2008) Identification of neurotransmitters and colocalization of transmitters in brainstem respiratory neurons. Respir Physiol Neurobiol 164(1-2):18-27
21. Kuwaki T (2010) Hypothalamic modulation of breathing. Adv Exp Med Biol 669:243-247
22. Horn EM, Waldrop TG (1998) Suprapontine control of respiration. Respir Physiol 114:201-211
23. Kayaba Y, Nakamura A, Kasuya Y, Ohuchi T, Yanagisawa M, Komuro I, Fukuda Y, Kuwaki T (2003) Attenuated defense response and low basal blood pressure in orexin knockout mice. Am J Physiol Regul Integr Comp Physiol 285:R581-R593
24. Young JK, Wu M, Manaye KF, Kc P, Allard JS, Mack SO, Haxhiu MA (2005) Orexin stimulates breathing via medullary and spinal pathways. J Appl Physiol 98:1387-1395
25. Williams RH, Burdakov D (2008) Hypothalamic orexins/hypocretins as regulators of breathing. Expert Rev Mol Med 10:e28
26. Gestreau C, Bévengut M, Dutschmann M (2008) The dual role of the orexin/hypocretin system in modulating wakefulness and respiratory drive. Curr Opin Pulm Med 14:512-518
27. Nattie E (2000) Multiple sites for central chemoreception: their roles in response sensitivity and in sleep and wakefulness. Respir Physiol 122:223-235
28. 2. Proc Natl Acad Sci USA 104:10685-10690
29. 2 activates orexin-containing neurons in mice. Respir Physiol Neurobiol 166:184-6
30. Dutschmann M, Kron M, Mörschel M, Gestreau C (2007) Activation of Orexin B receptors in the pontine Kölliker-Fuse nucleus modulates pre-inspiratory hypoglossal motor activity in rat. Respir Physiol Neurobiol 159:232-235
31. Zhang W, Shimoyama M, Fukuda Y, Kuwaki T (2006) Multiple components of the defense response depend on orexin: evidence from orexin knockout mice and orexin neuron-ablated mice. Auton Neurosci 126-127:139-145
32. Terada J, Nakamura A, Zhang W, Yanagisawa M, Kuriyama T, Fukuda Y, Kuwaki T (2008) Ventilatory long-term facilitation in mice can be observed during both sleep and wake periods and depends on orexin. J Appl Physiol 104:499-507
33. Strohl KP, Cherniack NS, Gothe B (1986) Physiologic basis of therapy for sleep apnea. Am Rev Respir Dis 134:791-802
34. 2 but not load compensation. Chest 84:695-698
35. Han F, Chen E, Wei H, He Q, Ding D, Strohl KP (2001) Treatment effects on carbon dioxide retention in patients with obstructive sleep apnea-hypopnea syndrome. Chest 119:1814-1819
36. Zhang Q, He QY, Du QY, Pang GF, Zhao LS, Wu RQ, Han F, Liu LC, Wang Y, Sun GX, Liu XY, Zhao ZW (2003) Epidemiologic study on sleep apnea-hypopnea syndrome by home investigation in Chengde city. Zhonghua Jie He He Hu Xi Za Zhi 26(5):273-275, Chinese
37. Fontana A, Gast H, Reith W, Recher M, Birchler T, Bassetti CL (2010) Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss? Brain 133:1300-1311